Nevertheless, no association between TET2 mutations and reduced expression of TDP1 was identified in human AML samples, confirming that this is not the only mechanism involved in the synthetic lethality of PARPi in TET2-mutated AML [82]. Here, TET2 is linked to acute myeloid leukemia.